Cytokine-induced killer cell treatment is superior to chemotherapy alone in esophageal cancer.

Authors:
Sun J; Sun Y; Miniderima; Wang X.

Journal:
Pathol Oncol Res

Publication Year: 2023

DOI:
10.3389/pore.2023.1610710

PMCID:
PMC10277884

PMID:
37342361

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pathol Oncol Res

Abbreviation: Pathol Oncol Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Clinical significance of integrin αV and β superfamily members and focal adhesion kinase activity i…
Sakurai S; Ishida Y; Shintani T and 6 more (2024) - Transparency Score: 2/6
Extracellular vesicles as modulators of glioblastoma progression and tumor microenvironment.
Dai J; Jiang Y; Hu H and 2 more (2024) - Transparency Score: 2/6
LINAC-based SBRT in treating early-stage NSCLC patients-single institution experience and survival …
Kovács Á; Trási K; Barabás M and 5 more (2024) - Transparency Score: 2/6
Stereotactic body radiotherapy in lung cancer: a contemporary review.
Csiki E; Simon M; Papp J and 5 more (2024) - Transparency Score: 2/6
3D bioprinting and the revolution in experimental cancer model systems-A review of developing new m…
Sztankovics D; Moldvai D; Petővári G and 5 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"Author contributions: Conceptualization: JS. Data curation: JS and XW. Formal analysis: JS and Miniderima. Funding acquisition: JS and XW. Investigation: JS and XW. Methodology: YS. Project administration: XW. Resources: XW. Software: JS and YS. Supervision: XW. Validation: XW. Visualization: Miniderima. Writing-original draft: JS and XW. Writing-review and editing: Miniderima. All authors contributed to the article and approved the submitted version."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025